Calnex Solutions Share Discussion Threads

[onjohn] 27/11/2020 06:37

Sorry I can’t go for that. No can do

[escapetohome] 26/11/2020 22:11

Rip roaring performance here, you may like to consider another 5G stock , Ethernity Networks, just £10m mkt cap, pursuing new market opportunities.

This is an opportunity to get in very close to the ground floor.

ENET are pursuing new growth avenues in 5 G network, enabling the network , and providing what could be a key part of the physical processing power and software for low latency and super super fast speed, that will be required.

Correct me if im wrong but this is to enable greater flexibility and connectivity between different systems and allowing greater integration in the future, is a disaggregated environment.


Good luck for the future in all your investments. Aim is high risk so dont forget that folks.

[dr biotech] 26/11/2020 19:02

Fwiw that’s not really a special offer, any new subscribers pay £130

I bought in here the morning (first thing) after it was tipped and paid 58p. So you don’t often get anywhere near the tip price. Having said that, I’ve made 50% in two months and even at my modest investment sizes (typically 5-6k in any smaller co) it’s been well worth it. Had some poor performances too.

[johndoe23] 26/11/2020 15:10

Only came across this yesterday evening, looks like one with bags of potential. Reluctant to buy in after a 108% rise recently though!!

[thomshrike] 26/11/2020 15:09

A few snippets:
- management seems to have a roadmap for the introduction of new products, which justifies the hiring of new R&D people.
- Last year FY revenue weighting was c. 45/55 between H1/H2. Outlook reflects conservative management view that some clients might have pre-ordered in H1 because of concerns with budget cuts or supply chain issues later in the year. On the other hand, some clients might have delayed orders into H2 because of ongoing uncertainty in H1.
- I got the feeling that their product is critical for clients. Some clients might not need to purchase more than 1 or few units, but they will continue to spend on software upgrades in the future. Because of that, (just my opinion) at some point the revenue growth rate might slow down but if that happens gross margins should increase.
- Travel-related cost savings in H1: c. 0.3m.
Well done Tommy!

[techno20] 26/11/2020 14:55

Been selling since yesterday from 91p up in the hope of buying back in cheaper. Strategy failing miserably so far!

[zingerburger] 26/11/2020 14:39

umm bit late for me now
just been emailed a black friday offer for scsw which tipped at 52p five weeks ago. shoulda listened to them.

[masurenguy] 26/11/2020 13:00

About an hour ago somebody paid 100p for 10,000 Calnex shares. That price represents a 108% increase on the IPO price just over 5 weeks ago. This has been an amazingly successful IPO thus far !

[rivaldo] 26/11/2020 07:32

The CEO is interviewed here:



He notes that "savings in travel and events costs due to Covid-19 restrictions .....would be replicated in part in the second half of the year", despite Cenkos' new forecasts not allowing for any savings being made in H2.

TC also confirms that the pandemic had "no impact", and that there are "no worries" about Brexit.

In summary:

"The need for new test instrumentation is being driven by the transition of the telecoms industry to 5G, along with exponential growth in data creation and the migration of industries to cloud computing."

[energeticbacker] 25/11/2020 18:19

Covered in Investor's Champion's latest update a business generating operating margins of 30% and a similar return on equity, supporting a growing market looks highly appealing.

[thomshrike] 25/11/2020 17:06

Some listed competitors: Keysight (a spin-off of Agilent), Viavi, Exfo, National Instruments. All of them American.

[dr biotech] 25/11/2020 16:40

Decent write up thanks H.

[nurdin] 25/11/2020 15:42

cheers....should have googled it,its all there lol

[hastings] 25/11/2020 15:41

Two or three big players but they don't seem that concerned. Quite a lot of smaller players with specific focus, hence fragmented.

[nurdin] 25/11/2020 15:30

Very good Hastings,many thanks.

Who are their main competitors, anyone know?

[masurenguy] 25/11/2020 15:26

Cheers Martin - interesting insight.

[hastings] 25/11/2020 15:17

Write up as mentioned, hopefully of interest.Https://martinflitton1.wixsite.com/privatepunter/post/calnex-set-for-further-growth-25-11-20

[dr biotech] 25/11/2020 10:34

As a new IPO I can see why they always want their first set of results to exceed market expectations so you could say its a (house) brokers job to aim on the low side. After that you expect them to go a bit the other way. Still I'm pretty sure all on here are sitting on a decent return in the short time we've had them.

[rivaldo] 25/11/2020 10:25

One-liners without any analysis at all really don't help very much!

- Cenkos themselves say today their forecasts are "conservative"
- they've increased estimates for R&D and sales expenses, yet have assumed that the COVID-19 cost benefits enjoyed in H1 will not reoccur at all in H2
- H1 revenues were £7.72m. Cenkos' forecast for the year is now £15.4m, implying that revenues will actually drop slightly in H2...
- Cenkos also, again "conservatively" as they say, do not add back R&D amortisation to reach their adjusted EBITDA - unlike other analysts
- they say it's "prudent to leave headroom in our expectations", and "should current trading levels continue....further upwards revisions to our forecasts are possible"

Draw your own conclusions.

[nesquikme] 25/11/2020 09:59

not much of an upgrade today

[rivaldo] 25/11/2020 09:03

Buying coming in at 92p now.

[nw99] 25/11/2020 08:42

Superb numbers

[nurdin] 25/11/2020 08:35

yup..excellent results.Cant add to anything that has already been said.

[thomshrike] 25/11/2020 08:27

Hi Hastings, thank you, pls do. My call is only tomorrow and I could then clarify any lingering doubts.

[techno20] 25/11/2020 08:19

Great results and market clearly likes them. Its rare to see IPO’s delivering value IMO, but CLX clearly has! Thanks again to Hastings and Rivaldo for flagging so early.